These findings indicate that FGFR1 activation may be dependent on FAPα to induce secretion of CXCL5 in HSCs and to promote tumor cell EMT and MDSC recruitment, thus facilitating vessel co-option. The gene discussed is FGFR1; the disease is neoplasm.